(Invitrogen Life Technologies), incubated at room temperature for 30 mins, added 1 7 4 dropwise to cells, and incubated at 37 o C overnight. CV-1 cells were infected with T1L, 1 7 5 rTC-μNS(C-term-T1L)/passage 5 (P5), or rTC-μNS(#7-T1L)/P5 at an MOI = 1 for 1 h 1 7 6 with shaking and then incubated at 37 o C overnight. For reverse genetics, 5.0x10 5 BHK-1 7 7 T7 cells were plated on a 6-well plate (9.5 cm 2 ) (Corning Inc.) and transfected as 1 7 8 previously described (27) . The cells were incubated for six days at which point cells and 1 7 9 media were subjected to three freeze/thaw cycles, and standard L929 cell plaque assays 1 8 0 were performed (34). Recovered plaques were passaged ten times on Vero cells for 7-28 1 8 1 days to allow for replication of slow growing virus. 1 8 2 2 8 and imaging on a ChemiDoc XRS Imaging System (Bio-Rad).
9
MRV genome analysis and reverse transcription. 1.0x10 8 PFUs of T1L, rTC-μNS(C-2 3 0 term-T1L)/P2, /P5, /P7, or /P10, or rTC-μNS(#7-T1L)/P2 or /P5 and 1.0x10 9 PFUs of 2 3 1 T1L (T1L 10X) were subjected to TRIzol LS (Life Technologies) extraction via 2 3 2 manufacturer's instructions. Briefly viruses were homogenized in TRIzol LS and the 2 3 3 addition of chloroform separated each sample into proteins, DNA, and RNA phases. The 2 3 4 RNA phase was collected and isopropanol and ethanol were added to precipitate and 2 3 5 wash RNA. Extracted RNA was separated on 10% SDS-PAGE at a constant 20 mA for 2 3 6 12 hrs, and the gel was incubated in water with 3X gel red (Phenix Research Products) 2 3 7 for 1 h and imaged on a ChemiDoc XRS Imaging System (Bio-Rad). Extracted RNA was 2 3 8 also subjected to reverse transcription (RT)-PCR using SuperScript IV (Invitrogen Life 2 3 9 Technologies) as per manufacturer's instructions for sequencing.
4 0
Live cell imaging of VFs. BHK-T7 and Vero cells were seeded on a 12 well, 14 mm 2 4 1 glass bottom plate (MatTek Corporation) at a concentration of 2x10 5 and 7.5x10 4 cells 2 4 2 per well, respectively, and then infected the following day with T1L at an MOI of 100, 2 4 3 rTC-μNS(C-term-T1L)/P2 at an MOI of 5 (BHK-T7 cells), or rTC-μNS(C-term-T1L)/P5 2 4 4 at an MOI of 100 (Vero cells). For BHK-T7 cells, at 18 h p.i., media was removed and 2 4 5 cells were washed twice with DMEM without phenol red (HyClone) supplemented with 2 4 6 penicillin (100 I.U./ml), streptomycin (100 μg/ml) solution, 1% MEM non-essential 2 4 7 amino-acids solution, and 25 mM HEPES (4-(2-Hydroxyethyl)piperazine-1-2 4 8 ethanesulfonic acid), followed by addition of FlAsH-EDT2 diluted to 2.5 μM in DMEM 2 4 9 and incubated at 37 o C with shaking every 15 mins for a total of 45 mins, at which point 2 5 0 800 μl of DMEM was added to each well and imaging was initiated. For Vero cells, at 10 2 5 1 h p.i. cells were washed and treated with FlAsH-EDT2 until 12 h p.i. at which point 2 5 2 FlAsH-EDT2 was removed, media was replenished and imaging was initiated. In 2 5 3 experiments involving nocodazole, at 6 h p.i. 10 μM nocodazole was added and 2 5 4 maintained throughout the experiment. All cells were examined using an Olympus IX071 2 5 5 inverted fluorescence microscope on a vibration table, equipped with an environmental 2 5 6 control chamber heated to 37 o C. Still images and video were captured through a 40x 2 5 7 apochromatic objective by a high resolution Hamamatsu CCD camera using MetaMorph 2 5 8
for Olympus MetaMorph Advanced (V 7.7.7.0). All image exposure conditions were 2 5 9 maintained throughout the experiment and background levels were set using FlAsH-2 6 0 EDT2 expression in wildtype T1L infected cells. Still images were processed using 2 6 1 ImageJ (2.0.0-rc-49/1.51d) and assembled for publication using Adobe Photoshop and 2 6 2 Illustrator (Adobe Systems).
6 3

Results
6 4
Construction of plasmids expressing the TC-tag from within the μNS protein.
6 5
Specific regions within the μNS protein have previously been identified that are required 2 6 6 for recruitment of the viral core and six other MRV proteins to VFs, and for forming VFs 2 6 7 (6, 7, 9, 10, 12) (Fig. 1A ). As our goal was to rescue a type 1 Lang (T1L) MRV virus 2 6 8 expressing the TC-tag, CCPGCC, from within the μNS protein, we reasoned that there 2 6 9 would be sites of insertion that would not allow rescue of virus as a result of interference 2 7 0 with μNS functions during infection. For this reason, to locate a position within the 2 7 1 protein that would be tolerated during virus infection, we inserted the nucleotide 2 7 2 sequence encoding CCPGCC at eight positions throughout a μNS-encoding M3 gene 2 7 3 expression plasmid. We initially reasoned that utilization of existing amino-acids of the 2 7 4 TC-tag from within the μNS protein may prevent disruption of μNS function and 2 7 5 constructed clones in which we incorporated the remainder of the tag into an existing PG, 2 7 6 by flanking the PG residues with two CC residues at AA 28 [TC-μNS(#1)], 132 [TC-2 7 7 μNS(#2)] and 334 [TC-μNS(#4)], or CP, by flanking the CP with a C and GCC at AA 2 7 8 491 [TC-μNS(#5)]. Although μNS is highly conserved between strains, to improve our 2 7 9 chance of success in rescuing a recombinant virus expressing a tagged μNS, we 2 8 0 performed a sequence comparison between the μNS protein from the three major MRV 2 8 1 serotypes (T1L, T2J, and T3D), and identified two areas of 6 AA that were not highly 2 8 2 conserved. We replaced these regions with CCPGCC in the T1L μNS (TC-μNS(#6)-AA 2 8 3 614 EAAAKC to CCPGCC, and TC-μNS(#7)-AA 545 QSLNAQ to CCPGCC). Finally, 2 8 4 we reasoned we may be able to rescue a virus where the μNS protein sequence was not 2 8 5 disrupted and the CCPGCC was added as a fusion to either the μNS amino (N)-or 2 8 6 carboxyl (C)-terminus to make TC-μNS(N-term) and TC-μNS(C-term) ( Fig. 1A ). the TC-tag does not ensure the protein will be labeled upon exposure to biarsenical 2 8 9 compounds as folding of the tagged protein may prevent or interfere with compound 2 9 0 binding. It is also plausible that the TC-tag would prevent VFL formation due to a 2 9 1 conformational change in μNS resulting in loss of μNS-μNS association. In order to 2 9 2 examine FlAsH-EDT2 labeling and VFL formation of the TC-μNS fusion proteins, we 2 9 3 transfected BHK-T7 cells with plasmids expressing each of the eight TC-tagged proteins.
9 4
At 18 h p.t., FlAsH-EDT2 reagent was added. We began to observe fluorescence within 2 9 5 15 mins in most samples (data not shown), that increased in intensity throughout the 2 9 6 labeling period of 90 mins, at which point the FlAsH-EDT2 reagent was removed and 2 9 7 cells were fixed and subjected to immunofluorescence assays with antibodies against 2 9 8 μNS, followed by Alexa 594-conjugated secondary antibodies ( Fig. 1B ). Upon 2 9 9 microscopic observation, we found colocalization of the FlAsH-EDT2 and μNS staining 3 0 0 formed less distinct VFLs with varying levels of diffuse μNS staining. TC-μNS(#2) and 3 1 0 TC-μNS(#5) did not form VFLs and instead were entirely diffuse in all transfected cells.
1 1
These results suggest that the TC-tag can be added at multiple sites throughout the μNS 3 1 2 protein without disrupting VFL formation and that the expressed TC-μNS protein was 3 1 3 label-competent utilizing FlAsH-EDT2.
1 4
Insertion of the TC-tag within the N-terminal two thirds of μNS leads to diminished 3 1 5 recruitment of viral proteins to VFLs. We hypothesized that we could also utilize these 3 1 6 mutants to learn more about μNS localization with MRV proteins by investigating the 3 1 7
interaction of each mutant with individual virus proteins that were previously identified 3 1 8 as μNS associating partners. We separated the TC-μNS mutants based on previously 3 1 9
identified functions of μNS to include the N-terminal third (AA 1-221), the central third 3 2 0 (AA 222-470), and the C-terminal third (AA 471-721). Previous studies have found that 3 2 1 the μNS N-terminal third is both necessary and sufficient to bind virus proteins σNS, μ2, 3 2 2 λ1, λ2, and σ2, the C-terminal third is necessary and sufficient to bind λ3, form VFs, and 3 2 3 bind cellular clathrin, and the central third, which has been implicated in recruiting 3 2 4 cellular protein Hsc70 to VFs (6, 7, 9, 10, 12, 35, 36) . To examine the impact of the 3 2 5
introduced TC-μNS mutations we co-transfected cells with each pTC-μNS mutant or 3 2 6 wildtype pT7-M3 along with plasmids expressing each of the other six virus proteins 3 2 7
individually. As TC-μNS(#2) and TC-μNS(#5) did not form VFLs, we did not examine 3 2 8 the impact of these mutations on μNS localization with other viral proteins. At 18 h p.t., 3 2 9 cells were fixed and stained with antibodies against μNS and each respective protein or 3 3 0 associated protein tag followed by Alexa 594-and 488-conjugated secondary antibodies.
1
Three representative pictures of each condition were acquired and μNS recruitment of λ1, 3 3 2 λ2, λ3, σ2, and σNS to VFLs, or μ2 recruitment of μNS to microtubules was quantified 3 3 3 by comparing the pixel intensity of μNS and associating proteins at VFLs or 3 3 4 microtubules. Each quantified interaction of TC-μNS and associating protein was made 3 3 5 relative to wildtype μNS and a student's t-test was used to determine if each TC-μNS 3 3 6 mutant was significantly decreased, (p < 0.05) denoted by a (-), from wildtype (Table 1) .
7
We found that each TC-μNS mutant had a statistically significant diminished proper μNS folding in these mutants. Altogether, these findings suggest that the C-3 4 6 terminus may be the most amenable region of μNS for TC-tag insertion.
4 7
Rescue of MRV expressing TC-μNS. All of the TC-μNS mutants were tested in a 3 4 8 plasmid based reverse genetics approach to attempt to rescue viruses containing the 3 4 9 CCPGCC motif in the μNS protein (17). Briefly, a modified version of the previously 3 5 0 described T7-driven, 4 and 10 plasmid systems was used (17). Three plasmids from the 3 5 1 four-plasmid system were used to provide 8 of the MRV genes (pT7-M1-S1-S2-S4, pT7-3 5 2 L3-S3, pT7-L1-M2). The L2 and M3 wildtype and M3 TC mutant genes were each 3 5 3 provided from individual plasmids (pT7-L2, pT7-M3/TC-M3 mutants). Plasmids were 3 5 4 co-transfected into BHK-T7 cells, and incubated for six days at which point cells and 3 5 5 media were harvested and subjected to three freeze/thaw cycles, followed by standard 3 5 6 MRV plaque assay on L929 cells (34). Three experiments were done for each mutant, 3 5 7 and wildtype M3 and no M3 plasmid positive and negative controls were included in 3 5 8 each experiment. To allow for slow growing viruses, plaque assays were incubated for 3 5 9 five days and monitored each day for plaques. In each experiment there were greater than 3 6 0 10 4 plaques formed in the positive control and no plaques formed in the negative control.
6 1
There were also no plaques recorded in any experiment with pTC-μNS(N-term), pTC-3 6 2 μNS(#1), pTC-μNS(#2), pTC-μNS(#4), pTC-μNS(#5) or pTC-μNS(#6). However, we 3 6 3 observed plaques forming from days 3-5 on a single experiment with pTC-μNS(#7) and 3 6 4 pTC-μNS(C-term), suggesting we had recovered rTC-μNS(#7-T1L) and rTC-μNS(C-3 6 5 term-T1L) viruses with TC-tagged μNS. Plaques were picked and the viruses were 3 6 6 passaged ten times on Vero cells to amplify the viruses. After two passages, CV-1 cells 3 6 7
were infected with recombinant viruses and were labeled with FlAsH-EDT2 18 h p.i. and 3 6 8 subsequently prepared for immunofluorescence to label μNS. We observed FlAsH-EDT2 3 6 9
labeling of μNS and VFs in cells infected with each virus (Fig. 2) . We additionally measured the plaque size of each virus and found that rTC-μNS(#7-3 8 6 T1L) and rTC-μNS(C-term-T1L) plaques were 55% and 45% the size of wildtype 3 8 7 plaques, respectively (Fig. 3B) . These findings suggest that addition of the TC-tag in the 3 8 8 C-terminal third of μNS inhibits viral infection relative to wildtype virus, however, both 3 8 9 rTC-μNS(#7-T1L) and rTC-μNS(C-term-T1L) replicated to titers that should be 3 9 0 sufficient for live cell imaging.
9 1
Recombinant viruses retain recruitment of μNS associating proteins to VFs. In an 3 9 2 attempt to explain the attenuated nature of rTC-μNS(#7-T1L) and rTC-μNS(C-term-T1L) 3 9 3
we examined μNS recruitment of viral proteins to VFs in cells infected with each 3 9 4 recombinant virus. CV-1 cells were infected with T1L, rTC-μNS(C-term-T1L)/P5, or 3 9 5 rTC-μNS(#7-T1L)/P5 at an MOI of 1 and at 18 h p.i. cells were fixed and stained with 3 9 6 antibodies against μNS and σNS, λ2, μ2, or the core particle followed by Alexa 594-and 3 9 7 488-conjugated secondary antibodies ( Fig. 4A-C) . The core antibody has been shown to 3 9 8 bind λ1, λ2, and σ2 (6), and we do not have access to an antibody that specifically 3 9 9 detects λ3. We observed recruitment of σNS, λ2, and the core proteins to VFs and 4 0 0 recruitment of VFs to microtubules in both recombinant viruses, with rTC-μNS(C-term-4 0 1 T1L) displaying a qualitatively more similar phenotype to wildtype virus compared to 4 0 2 rTC-μNS(#7-T1L) ( Fig. 4) , which consistently possessed somewhat smaller VFs than and samples were collected at 0, 12, 24, and 48 h p.i. and subjected to immunoblot 4 2 0 analysis with antibodies against μNS, to examine specific impacts of the TC-tag insertion 4 2 1 on μNS expression, and against σNS, to examine expression of a viral protein other than 4 2 2 μNS. Antibodies against α-tubulin were also used as a protein loading control (Fig. 5A ).
2 3
We observed that both recombinant viruses expressed substantially higher amounts of 4 2 4 μNS and σNS compared to wildtype T1L at each timepoint, suggesting that the TC-tag 4 2 5 within μNS does not disrupt μNS protein expression, and that the recombinant viruses 4 2 6
were not defective at early stages of infection including virus entry, RNA transcription, 4 2 7 and protein translation. Importantly, this data also suggested that substantially more 4 2 8 recombinant virions may be required to achieve the same PFU relative to wildtype virus.
2 9
To explore this hypothesis, we examined the virus preparations directly by 4 3 0 subjecting identical PFUs of the same wildtype and recombinant virus stocks to 4 3 1 immunoblot analysis with antibodies against the virion, which detected substantially 4 3 2 more virions/PFU in the recombinant viruses compared to wildtype (Fig. 5B ). We 4 3 3 additionally examined genomic RNA associated with the same PFUs of wildtype and 4 3 4 recombinant virus, and again found that there were substantially higher levels of genome 4 3 5 associated with the same PFU of recombinant viruses relative to wildtype (Fig. 5C ).
3 6
Finally, a repeated plaque assay of the same stocks showed that the PFUs between the 4 3 7 viruses remained essentially the same (Fig. 5D ). Together these findings suggest that the (Fig. 6A) . By passage five the 4 5 2 virus had stabilized and exclusively contained the C550Y mutation. This data showed 4 5 3 that our earlier FlAsH-EDTA labeling experiments using rTC-μNS(#7-T1L)/P2 4 5 4 contained a mixed population of virus (Fig. 2 ). As this labeling was diminished relative to 4 5 5 rTC-μNS(C-term-T1L), we were curious whether the labeling defect was a result of the 4 5 6 C550Y mutation or whether this mutation would lead to a complete loss of labeling.
5 7
Therefore, we infected CV-1 cells with rTC-μNS(#7-T1L)/P5 which contained the 4 5 8
CCPGCY mutation exclusively to determine if μNS would label with FlAsH-EDT2. We 4 5 9 found that VF labeling was similarly diminished using this passage, suggesting that the 4 6 0 FlAsH-EDT2 reagent was able to maintain binding, albeit to a lesser extent, to the 4 6 1 CCPGCY sequence (Fig. 6B ).
6 2
Sequencing the M3 gene of passage two of the rTC-μNS(C-term-T1L) virus also 4 6 3 showed a mixed population of viruses in which the CCPGCC TC-tag itself remained 4 6 4 stable but the virus had acquired a second-site mutation at 2153C>T, that resulted in a 4 6 5 T718I mutation within the protein upstream of the TC-tag (Fig. 6C ). This mutation 4 6 6 became dominant by passage five. To determine if this was a stable mutation we 4 6 7 passaged the rTC-μNS(C-term-T1L) virus five further passages and again sequenced the 4 6 8 M3 genome segment at passage seven and ten. We found that the seventh passage virus 4 6 9 exclusively contained the T718I mutation and this mutation remained stable at passage 4 7 0 ten ( Fig. 6C ) while both passages retained the original CCPGCC TC-tag. We performed 4 7 1 replication assays on wildtype T1L, rTC-μNS(C-term-T1L)/P2, and rTC-μNS(C-term-4 7 2 T1L)/P7 followed by plaque assays to determine if the T718I mutation restored the virus 4 7 3 to wildtype T1L replication kinetics or impacted replication in any way, but we observed 4 7 4 no significant difference between the two passages (data not shown). Because the rTC-4 7 5 μNS(C-term-T1L) TC-tag remained stable over ten passages and labeled with FlAsH-4 7 6 EDT2 to higher levels than rTC-μNS(#7-T1L), we proceeded forward using the rTC- stochastic motions in the cell while larger, more stationary VFs were found at the nuclear 4 8 9 periphery (Fig. 7B, Supplementary Mov. 1) . Small VFs were highly mobile and could be 4 9 0 seen fusing with larger VFs (Fig. 7B: red arrows) . In addition, small VFs could be seen 4 9 1 moving towards one another or towards larger VFs, touching briefly, and then moving 4 9 2 away in a kissing motion ( Fig. 7B : yellow arrow) which may be a result of incomplete 4 9 3 VF fusion. These data suggest that rTC-μNS(C-term-T1L) will be an extremely useful 4 9 4 tool for future in depth studies examining VF dynamics and function during MRV 4 9 5 infection.
9 6
VF dynamics in the presence of nocodazole. In addition to facilitating our 4 9 7 understanding of VF formation and movement throughout infection, we postulated that 4 9 8 rTC-μNS(C-term-T1L) will also be indispensable for understanding the role of VF 4 9 9
interactions with cellular proteins throughout infection. One such interaction that has 5 0 0 been previously defined is that of μNS and the μNS-interacting protein, μ2, with cellular 5 0 1 microtubules (MTs). Destabilization of MTs leads to the formation of small VFs/VFLs 5 0 2 concentrated at the periphery of the cell in infected cells or cells transfected with a 5 0 3 plasmid expressing μNS, suggesting MTs play a critical role in VF/VFL movement or 5 0 4 fusion (9, 33). In addition, the μ2 protein of most MRV strains induces hyperacetylation 5 0 5 and stabilization of MTs and also influences the morphology of VFs to a more 5 0 6 filamentous, rather than globular VFL phenotype seen when μNS is expressed alone (9, 5 0 7 33). Until recently, most evidence suggested that tight association of VFs with MTs (14) 5 0 8 or MT stability (37) in MRV infected cells does not significantly alter viral replication.
0 9
However, a recent paper has suggested that MT disruption significantly decreases MRV which destabilizes MTs (Fig. 8A ). At 10 h p.i. cells were labeled with FlAsH-EDT2 and 5 1 7 at 12 h p.i. FlAsH-EDT2 was removed and still images were taken of VFs every 2 mins 5 1 8 for 2 h. In cells not treated with nocodazole we observed stable filamentous VFs that 5 1 9
were presumably MT-associated as well as globular VFs which exhibited fluid movement 5 2 0 around the cell resulting in some VF fusion events (Fig. 8B, red Mov. 2) similar to those observed in BHK-T7 cells. We also identified a new fusion 5 2 2 event in which a small VF moves from the microtubule toward a large VF, fuses, and 5 2 3 then pulls the large VF toward the microtubule at which point the large VF fuses with VF 5 2 4 material already on the microtubules (Fig. 8B , blue arrows, Supplementary Mov. 2).
2 5
While this interaction has not previously been identified it might suggest that smaller, 5 2 6 more dynamic VFs may be instrumental in assisting and/or facilitating VF fusion. We 5 2 7 also recorded disruption of two VFs in close proximity by movement of other VFs 5 2 8 directly between them (Supplementary Mov. 2, green arrow).
2 9
In cells treated with nocodazole, there was no obvious association of VFs with 5 3 0
MTs, and all VFs were globular and not filamentous in nature, as expected. Somewhat 5 3 1 surprisingly, the VFs appeared to be very dynamic exhibiting short stochastic movements 5 3 2 throughout the cell (Fig. 8C , green arrows, Supplementary Mov. 3). While we observed 5 3 3 VF movement we did not see accumulation of VFs at the nuclear periphery that we 5 3 4 observed in cells without nocodazole treatment. We were also unable to detect any VF 5 3 5 fusion events throughout multiple experiments, and instead repeatedly imaged multiple 5 3 6 clusters of small VFs that appeared unable to fuse (Fig. 8C , yellow arrow, Supplementary 5 3 7
Mov. 3). Together this suggests that the small VF phenotype previously observed 5 3 8 following nocodazole treatment in fixed cells (9, 33) is likely a result of an inhibition or 5 3 9 inability of VFs to fuse with one another and not a result of total inhibition of VF 5 4 0 movement within the cell. In addition to defining a role for MTs in VF fusion and 5 4 1 migration, this result further suggests that VFs are able to utilize cellular components 5 4 2 apart from microtubules to move within cells.
4 3
Discussion 5 4 4
In this paper we have demonstrated recovery of T1L recombinant MRV with a 5 4 5 TC-tag introduced into the non-structural VF matrix protein, μNS. This is the first time a 5 4 6
replicating recombinant MRV has been created in which VFs encoded from the genome 5 4 7 can be fluorescent labeled during infection. Adding the TC-tag to μNS in a recombinant 5 4 8
